Stifel Financial’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$967K Sell
30,037
-18,289
-38% -$677K ﹤0.01% 2478
2025
Q4
$2.03M Sell
48,326
-5,415
-10% -$218K ﹤0.01% 1913
2025
Q3
$1.84M Buy
53,741
+21,038
+64% +$604K ﹤0.01% 1974
2025
Q2
$884K Buy
32,703
+21,407
+190% +$620K ﹤0.01% 2410
2025
Q1
$335K Buy
11,296
+415
+4% +$15.8K ﹤0.01% 2915
2024
Q4
$431K Sell
10,881
-2,211
-17% -$83.7K ﹤0.01% 2764
2024
Q3
$446K Sell
13,092
-19,420
-60% -$546K ﹤0.01% 2743
2024
Q2
$705K Buy
32,512
+1,563
+5% +$32.9K ﹤0.01% 2398
2024
Q1
$686K Buy
30,949
+3,491
+13% +$85.2K ﹤0.01% 2425
2023
Q4
$755K Buy
27,458
+2,392
+10% +$57.7K ﹤0.01% 2314
2023
Q3
$560K Buy
25,066
+38
+0.2% +$977 ﹤0.01% 2436
2023
Q2
$637K Buy
25,028
+116
+0.5% +$2.81K ﹤0.01% 2379
2023
Q1
$556K Sell
24,912
-24
-0.1% -$580 ﹤0.01% 2458
2022
Q4
$592K Sell
24,936
-8,791
-26% -$204K ﹤0.01% 2378
2022
Q3
$560K Sell
33,727
-351
-1% -$7.9K ﹤0.01% 2365
2022
Q2
$678K Buy
34,078
+7,025
+26% +$142K ﹤0.01% 2282
2022
Q1
$746K Buy
27,053
+2,294
+9% +$65.6K ﹤0.01% 2321
2021
Q4
$1.02M Buy
24,759
+7,336
+42% +$324K ﹤0.01% 2115
2021
Q3
$809K Buy
17,423
+2,171
+14% +$94.7K ﹤0.01% 2256
2021
Q2
$610K Buy
15,252
+2,336
+18% +$99.9K ﹤0.01% 2466
2021
Q1
$694K Sell
12,916
-1,279
-9% -$73.7K ﹤0.01% 2262
2020
Q4
$694K Sell
14,195
-24
-0.2% -$1.11K ﹤0.01% 2110
2020
Q3
$462K Buy
14,219
+421
+3% +$13.4K ﹤0.01% 2134
2020
Q2
$358K Sell
13,798
-780
-5% -$19.4K ﹤0.01% 2239
2020
Q1
$354K Buy
14,578
+1,267
+10% +$31.9K ﹤0.01% 2083
2019
Q4
$369K Sell
13,311
-59
-0.4% -$1.53K ﹤0.01% 2435
2019
Q3
$320K Sell
13,370
-67
-0.5% -$1.78K ﹤0.01% 2412
2019
Q2
$383K Buy
+13,437
New +$336K ﹤0.01% 2342

Other funds holding VCYT

Stifel Financial's VCYT Position: Q1 2026 in Review

Stifel Financial reduced its Veracyte (VCYT) stake by 38% in Q1 2026, selling an estimated $677K and leaving 30,037 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

Stifel Financial first reported a position in VCYT in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.03M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Stifel Financial held 30,037 shares of Veracyte worth $967K as of Q1 2026.
  • Stifel Financial sold 18,289 Veracyte shares in Q1 2026, an estimated $677K.
  • Veracyte made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2478 holding.
  • Stifel Financial first reported a position in Veracyte in Q2 2019 and has held it in 28 quarters since.
  • Stifel Financial's Veracyte position peaked at $2.03M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.